Thus, mda-7/IL-24 expression appears to be shut down during tumor evolution, explaining the delayed, rather than complete, suppression of tumor formation in the doxycycline-treated mice, and the robust growth of these tumors once formed. The gene discussed is IL24; the disease is neoplasm.